Autogenous vaccine therapy for condyloma acuminatum. A double-blind controlled study.

AUTOR(ES)

Malison, M D

RESUMO

In an attempt to substantiate claims that autogenous vaccine is an effective form of immunotherapy for condyloma acuminatum, a double-blind cross-over study was carried out on 34 patients, in which autogenous wart vaccine was compared with a placebo vaccine identically prepared from each patient's own normal skin. It was found that the duration of disease was an important determinant of curability in patients with condylomata acuminata (P less than 0.001) and that when this factor was taken into account autogenous wart vaccine was not significantly more effective than the placebo (P = 0.43).

Documentos Relacionados

• Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.
• Phenylethylmalonamide in essential tremor. A double-blind controlled study.
• Letter: Griseofulvin therapy in Herpes progenitalis (a double-blind controlled trial).
• Long-term azathioprine in rheumatoid arthritis: a double-blind study.
• Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine and with placebo. A double-blind partner-controlled study.